Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 19, Number 4—April 2013

Research

Effect of 10-Valent Pneumococcal Vaccine on Pneumonia among Children, Brazil

Eliane Terezinha Afonso, Ruth Minamisava, Ana Luiza Bierrenbach, Juan Jose Cortez Escalante, Airlane Pereira Alencar, Carla Magda Domingues, Otaliba Libanio Morais-Neto, Cristiana Maria Toscano, and Ana Lucia AndradeComments to Author 
Author affiliations: Federal University of Goiás, Goiania, Goiás, Brazil (E.T. Afonso, R. Minamisava, A.L. Bierrenbach, O.L. Morais-Neto, C.M. Toscano, A.L. Andrade); Pontifical Catholic University of Goiás, Goiania (E.T. Afonso); Ministry of Health, Brasilia, Brazil (J.J.C. Escalante, C.M. Domingues); University of Brasília, Brasília (C.M. Domingues); University of São Paulo, São Paulo, Brazil (A.P. Alencar)

Main Article

Table 1

Rates of hospitalization for pneumonia among children 2 months–2 years of age, Brazil, prevaccination period, 2005–2009*

City No. cases, annual mean (± SD) Rates, annual mean (± SD) % Hospitalizations for pneumonia/hospitalizations for all respiratory causes % Hospitalizations for pneumonia/hospitalizations for all causes
Belo Horizonte 939 (133) 1.643 (217) 53.4 34.8
Curitiba 359 (49) 790 (114) 72.2 27.9
Recife 538 (41) 1.304 (107) 47 23.4
São Paulo 3999 (312) 1.247 (103) 61.4 36.1
Porto Alegre 292 (38) 863 (112) 25.8 15

*Pneumonia identified by International Classification of Diseases, 10th Revision, codes: J12–J18.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO